Skip to main content

Table 2 CSF white cell counts and cytology results in group I. WCC in the various subgroups

From: Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients

 

Units

Total

 ≤ 14 d

 > 14 d

Acute B/SC subgroup

Acute PN/CN/H subgroup

 Pleocytosis

Samples

14/128 (10.9%)

12/88 (13.6%)

2/26 (7.7%)

11/71 (15.5%)

1/16 (6.3%)

 WCC, all samples

Cells/µl

2 (0–651;128)

2 (0–651;88)

1 (0–8;26)

2 (0–651;70)

2 (0–8;16)

 WCC, if elevated

Cells/µl

10 (6–651;14)

11 (8–651;12)

7 (6–8;2)

12 (8–651;11)

8 (8–8;1)

 WCC, ≥ 100

Samples

4/128 (3.1%)

4/88 (4.5%)

0/26 (0%)

4/71 (5.6%)

0/16 (0%)

 WCC, if ≥100

Cells/µl

441.5 (247–651;4)

441.5 (247–651;4)

n.a. (n.a.;0)

441.5 (247–651;4)

n.a. (n.a.;0)

 Lymphocytes

Samples

66/80 (82.5%)

47/56 (83.9%)

14/18 (77.8%)

36/44 (81.8%)

10/11 (90.9%)

 Monocytes

Samples

67/80 (83.8%)

49/56 (87.5%)

13/18 (72.2%)

37/44 (84.1%)

11/11 (100%)

 Neutrophils

Samples

17/80 (21.3%)

14/56 (25%)

2/18 (11.1%)

10/44 (22.7%)

4/11 (36.4%)

 Eosinophils

Samples

0/80 (0%)

0/56 (0%)

0/18 (0%)

0/44 (0%)

0/11 (0%)

 Basophils

Samples

0/80 (0%)

0/56 (0%)

0/18 (0%)

0/44 (0%)

0/11 (0%)

 Plasma cells

Samples

2/80 (2.5%)

1/56 (1.8%)

1/18 (5.6%)

1/44 (2.3%)

0/11 (0%)

 Lymphoid cells

Samples

7/80 (8.8%)

5/56 (8.9%)

2/18 (11.1%)

3/44 (6.8%)

2/11 (18.2%)

 Macrophages

Samples

2/80 (2.5%)

2/56 (3.6%)

0/18 (0%)

1/44 (2.3%)

1/11 (9.1%)

 No pleocytosis

Samples

114/128 (89.1%)

76/88 (86.4%)

24/26 (92.3%)

60/71 (84.5%)

15/16 (93.8%)

  1. Results are given as medians (with ranges and sample numbers in brackets) and frequencies (with percentages in brackets), respectively
  2. B/SC brain/spinal cord, CSF cerebropinal fluid, PN/CN/H peripheral nerve/cranial nerve/headache only, WCC white cell count